Plain-English translation of NCT06436326 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial compares two ways to check blood sugar during pregnancy in women with gestational diabetes: a traditional blood glucose meter (where you prick your finger) versus a continuous glucose monitoring device (a small wearable sensor that tracks sugar levels all day). Researchers want to see if the continuous glucose monitor helps improve health outcomes for both mothers and babies, and whether cultural or economic factors affect how well each method works.
Gestational diabetes—high blood sugar during pregnancy—is becoming more common worldwide and can harm both mother and baby if not well controlled. While the continuous glucose monitor works well for other types of diabetes, doctors don't yet know if it's better for pregnancy diabetes, especially for people with different diets and living situations.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to use either a traditional blood glucose meter or a continuous glucose monitor from weeks 24–32 of pregnancy through delivery. You'll wear the device (or use the meter) for two 14-day periods, then receive a report on your glucose patterns. You'll also complete questionnaires and have blood tests at three time points: mid-pregnancy (24–32 weeks), late pregnancy (35 weeks to delivery), and after delivery (4–12 weeks postpartum).
AI-generated summary from trial data · Oct 12, 2026 · Not medical advice
Taiwan